Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Capabilities
Suggested News & Insights
Sidley Represents Axsome Therapeutics in its Acquisition of Global Rights to Balipodect from TakedaApril 3, 2026Sidley Advises Shield AI on Acquisition of AechelonMarch 26, 2026Sidley Represents Bonaccord Capital in Minority Investment in Prime FinanceMarch 26, 2026Sidley Represents Diversis Capital in Its Acquisition of LTi Technology SolutionsMarch 25, 2026Sidley Represented Thompson Street Capital Partners in Its Investment in Karpel Computer SystemsMarch 25, 2026Sidley Represents Apollo Funds in Minority Investment in SyntegonMarch 23, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory